
Drogas antituberculose: interações medicamentosas, efeitos adversos e utilização em situações especiais - parte 2: fármacos de segunda linha
Author(s) -
Marcos Abdo Arbex,
Marília de Castro Lima Varella,
Hélio Ribeiro de Siqueira,
Fernando Augusto Fiúza de Mello
Publication year - 2010
Publication title -
jornal brasileiro de pneumologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 39
eISSN - 1806-3756
pISSN - 1806-3713
DOI - 10.1590/s1806-37132010000500017
Subject(s) - medicine , humanities , philosophy
The main objectives of tuberculosis therapy are to cure the patients and to minimize the possibility of transmission of the bacillus to healthy subjects. Adverse effects of antituberculosis drugs or drug interactions (among antituberculosis drugs or between antituberculosis drugs and other drugs) can make it necessary to modify or discontinue treatment. We describe the general mechanism of action, absorption, metabolization, and excretion of the drugs used to treat multidrug resistant tuberculosis (aminoglycosides, fluoroquinolones, cycloserine/terizidone, ethionamide, capreomycin, and para-aminosalicylic acid). We describe adverse drug reactions and interactions (with other drugs, food, and antacids), as well as the most appropriate approach to special situations, such as pregnancy, breastfeeding, liver failure, and kidney failure.